You are here: Home › Resource Center for Research › Funding Opportunity Announcements › International Research Collaboration on Drug Abuse and Addiction Research (R01): PA-12-040

International Research Collaboration on Drug Abuse and Addiction Research (R01): PA-12-040

http://grants.nih.gov/grants/guide/pa-files/PA-12-040.html

FOA Purpose: This Funding Opportunity Announcement (PA) encourages collaborative research applications on drug abuse and addiction that take advantage of special opportunities that exist outside the United States. Special opportunities include access to unusual talent, resources, populations, or environmental conditions in other countries that will speed scientific discovery. Projects should  have relevance to the mission of NIDA and where feasible should address NIDAs scientific priority areas. While the priorities will change from year to year, in FY12 priority areas include: linkages between HIV/AIDS and drug abuse, and prevention, initiation, and treatment of nicotine and tobacco use (especially among vulnerable populations such as children, adolescents, pregnant women, and those with co-morbid disorders).

Letter of Intent Due Date: Not applicable.

Investigator notification of LOI acceptance: Standard dates apply, by 5:00 PM local time of applicant organization.

Application Due Date(s): January 8, 2015

Funding

The project is supported by grant 8U54MD007587-03 (RCMI Clinical and Translational Research award, University of Puerto Rico Medical Sciences Campus) from the National Institute on Minority Health and Health Disparities (NIMHD), a component of the National Institutes of Health (NIH). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of NIMHD or NIH.

Consortium Institutions

The Puerto Rico Clinical and Translational Research Consortium is a collaborative project of the the University of Puerto Rico Medical Sciences Campus, Universidad Central del Caribe and Ponce School of Medicine and Health Sciences.